Since MSPs have platelet-derived growth factor receptor α (PDGFRα) and are the origin of adipogenesis and fibrosis in skeletal muscle under pathological conditions, several tyrosine kinase inhibitors have been investigated as potential candidates to suppress fibroblast proliferation in DMD. The gene discussed is PDGFRA; the disease is Duchenne muscular dystrophy.